Heroin Dreams & Gas Station Kratom: The Dopey Kratom Deep Dive with Jana Wu
·1 hr 45 min
1. Dopey: On the Dark Comedy of Drug Addiction centers this Wednesday episode on a kratom deep dive with Jana Wu.
2. Dave hosts Jana Wu, who is identified as Mountainside's director of clinical and cultural integration and as a kratom expert.
3. The episode asks what kratom is doing in Connecticut, Florida, California, and the wider U.S. market right now.
4. Jana says the FDA is trying to get the DEA to schedule 7-hydroxy-mitragynine, which she describes as a major kratom-related development.
5. She says Connecticut classified kratom as Schedule I and set a March 24 or March 25 deadline for products to come off shelves.
6. Jana describes going into vape shops and gas stations after the state warning and hearing that some stores removed kratom immediately to avoid fines.
7. She says many of the customers she heard about were women in their 30s and 40s buying kratom for energy and pain relief.
8. Jana describes people buying pills, small shot bottles, and powdered products at the counter, sometimes before paying.
9. She says some heavy users dose all day because they have built a tolerance and dependency, then feel withdrawal when they cannot get more.
10. Jana links that pattern to Florida, where she says kratom was pulled quickly from shelves in July and people came to her support group in distress.
11. She says some people did not realize they were addicted because the product was legal and over the counter.
12. Jana says kratom use can lead some people back to alcohol, Suboxone, or other opioids after they had been abstinent.
13. She names anxiety, hyperpigmentation, hair loss, testosterone changes, constipation, stomach pain, and itchy skin as effects she has seen or read about.
14. Dave and Jana talk through the difference between kratom leaf, powder, extracts, tinctures, and 7-hydroxy-mitragynine.
15. Jana says the problem is less the plant itself than the way it is sold, distributed, and sometimes contaminated with heavy metals or toxins.
16. She also says the market is moving faster than research and legislation, which leaves consumers in a patchwork of state rules.
17. The conversation stays informal and improvised, with Dave interrupting for side questions, reader comments, and a long comparison to alcohol.
18. Jana keeps the tone clinical but conversational, shifting between policy details, roadside field reporting, and examples from her support group.
19. People following kratom policy, harm reduction, or recovery medicine would get the most from this episode.
20. Listeners wanting a tight comedy show with no policy discussion may skip it.
